Media event: |
The latest on new generation compounds and new therapeutic approaches - an exclusive update on progress in the Boehringer Ingelheim pipeline. |
|---|---|
Venue: |
Biberach, Germany, 17 Oct. 2008, 10:30 hrs (CEST) |
2nd International Boehringer Ingelheim Research & Development Press Conference
Background information for medical media outside the US only
Disease
Research & Development
-
Dr Andreas Barner
Vice-Chairman of the Board of Managing Directors and Head of Corporate Board Division Pharma Research, Development and Medicine,
Boehringer IngelheimFrom Curiosity to Discovery:
Boehringer Ingelheim Research & Development -
Dr Michel Pairet
Corporate Senior Vice President Research, Boehringer Ingelheim
The Power of Curiosity
How creativity can fill the pipeline -
Prof. Matthias Blueher
Head Clinical Research Group Atherobesity (Assistant Professor),
University Hospital LeipzigType 2 Diabetes
A new perspective on a growing epidemic and the need for continued development -
Prof. Klaus Dugi
Corporate Vice President Medical Affairs, Boehringer Ingelheim
Discovery in Diabetes: Boehringer Ingelheim enters Diabetes
The latest on new generation compounds and new therapeutic approaches
Presentation together with Dr Michael Mark. -
Dr Michael Mark
Vice President Metabolic Diseases Research, Boehringer Ingelheim
Discovery in Diabetes: Boehringer Ingelheim enters Diabetes
The latest on new generation compounds and new therapeutic approaches
Presentation together with Prof. Klaus Dugi. -
Dr Manfred Haehl
Corporate Senior Vice President Medicine, Boehringer Ingelheim
Discovery in Action
Landmark Trials & Pipeline Update
-
Videos
-
Entry into Type 2 Diabetes
Dr Andreas Barner talks about progress in research, the Boehringer Ingelheim pipeline and potential future medications in diabetes
(Vice-Chairman of the Board of Managing Directors and Head of Corporate Board Division Pharma Research, Development and Medicine, Boehringer Ingelheim).- Watch Video(FLV)
-
International R&D Press Conference
Highlights from Boehringer Ingelheim´s 2nd International Research & Development Press Conference in Biberach (Germany).
-
-
Images
-
R&D facility at the Biberach site (Germany)
Boehringer Ingelheim´s largest R&D centre in Biberach (Germany)
-
R&D Press Conference 2008
Boehringer Ingelheim´s 2nd International Research & Development Press Conference in Biberach (Germany) on 17 Oct. 2008
-
Dr Barner: Entry into Diabetes Field
Dr Andreas Barner announces entry into new therapeutic area Diabetes
(Vice-Chairman of the Board of Managing Directors and Head of Corporate Board Division Pharma Research, Development and Medicine, Boehringer Ingelheim) -
Boehringer Ingelheim's 2nd International R&D Press Conference.
The power of curiosity leads to new discoveries at Boehringer Ingelheim.
-
R&D facility at the Biberach site (Germany)
Boehringer Ingelheim´s largest R&D centre in Biberach (Germany)
-
R&D facility at the Biberach site (Germany)
Boehringer Ingelheim´s largest R&D centre in Biberach (Germany)
-
R&D facility at the Biberach site (Germany)
Boehringer Ingelheim´s largest R&D centre in Biberach (Germany)
-
Albert Einstein quotation: Curiosity
"The important thing is not to stop questioning, curiosity has its own reason for existing." Albert Einstein
-
